Meloksikam (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Meloksikam" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

13nih.gov

4^th place

8^th place

9doi.org

2^nd place

5^th place

4web.archive.org

1^st place

2^nd place

3drugs.com

399^th place

169^th place

3semanticscholar.org

11^th place

51^st place

2cbz.si

low place

607^th place

2fda.gov

447^th place

409^th place

1baudaxbio.com

low place

1books.google.com

3^rd place

11^th place

1wiley.com

222^nd place

163^rd place

1tandfonline.com

507^th place

185^th place

1worldcat.org

5^th place

10^th place

1archive.org

6^th place

9^th place

archive.org

Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C (Oktober 1995). »Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance«. Inflammation Research. 44 (10): 423–433. doi:10.1007/BF01757699. PMID 8564518. S2CID 37937305.

baudaxbio.com

»Baudax Bio Announces FDA Approval of Anjeso for the Management of Moderate to Severe Pain«. Baudax Bio, Inc. (tiskovna objava). 20. februar 2020. Arhivirano iz spletišča dne 21. februarja 2020. Pridobljeno 20. februarja 2020.

books.google.com

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. str. 519. ISBN 9783527607495. Arhivirano iz spletišča dne 10. julija 2020. Pridobljeno 30. junija 2020.

cbz.si

http://www.cbz.si/cbz/bazazdr2.nsf/Search?SearchView&Query=(%5BJENALISTI%5D=1)+(%5BSEZNAMUCINKNAZIV%5D=_Meloksikam*)&SearchOrder=4&SearchMax=301 Centralna baza zdravil, vpogled: 6. 4. 2022.
http://www.cbz.si/cbz/bazazdr2.nsf/o/2D3D6175BF5CB3CEC12579C2003F4B9B/$File/s-026166.pdf^{[mrtva povezava]} Povzetek glavnih značilnosti zdravila Movalis, vpogled: 7. 4. 2022.

doi.org

Noble S, Balfour JA (Marec 1996). »Meloxicam«. Drugs. 51 (3): 424–430, discussion 431–432. doi:10.2165/00003495-199651030-00007. PMID 8882380.
Stamm O, Latscha U, Janecek P, Campana A (Januar 1976). »Development of a special electrode for continuous subcutaneous pH measurement in the infant scalp«. American Journal of Obstetrics and Gynecology. 124 (2): 193–195. doi:10.1016/S0002-9378(16)33297-5. PMID 2012.
Hawkey C, Kahan A, Steinbrück K, Alegre C, Baumelou E, Bégaud B, in sod. (september 1998). »Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment«. British Journal of Rheumatology. 37 (9): 937–945. doi:10.1093/rheumatology/37.9.937. PMID 9783757.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Dequeker J, Hawkey C, Kahan A, Steinbrück K, Alegre C, Baumelou E, in sod. (september 1998). »Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis«. British Journal of Rheumatology. 37 (9): 946–951. doi:10.1093/rheumatology/37.9.946. PMID 9783758.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Wojtulewski JA, Schattenkirchner M, Barceló P, Le Loët X, Bevis PJ, Bluhmki E, Distel M (april 1996). »A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis«. British Journal of Rheumatology. 35 Suppl 1: 22–28. doi:10.1093/rheumatology/35.suppl_1.22. PMID 8630632.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Zeidan, Anwar Z.; Al Sayed, Bashar; Bargaoui, Naceur; Djebbar, Mourad; Djennane, Malik; Donald, Royden; El Deeb, Khamis; Joudeh, Raed A.; Nabhan, Abdullah; Schug, Stephan A. (april 2013). »A Review of the Efficacy, Safety, and Cost-Effectiveness of COX-2 Inhibitors for Africa and the Middle East Region: COX-2 Inhibitors in Pain Management«. Pain Practice. 13 (4): 316–331. doi:10.1111/j.1533-2500.2012.00591.x. PMID 22931375. S2CID 205715393. Pridobljeno 18. maja 2021.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Gates, Brian J.; Nguyen, Trang T.; Setter, Stephen M.; Davies, Neal M. (1. oktober 2005). »Meloxicam: A reappraisal of pharmacokinetics, efficacy and safety«. Expert Opinion on Pharmacotherapy. 6 (12): 2117–2140. doi:10.1517/14656566.6.12.2117. ISSN 1465-6566. PMID 16197363. S2CID 25512189. Pridobljeno 18. maja 2021.
Singh G, Lanes S, Triadafilopoulos G (Julij 2004). »Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam«. The American Journal of Medicine. 117 (2): 100–106. doi:10.1016/j.amjmed.2004.03.012. PMID 15234645.
Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C (Oktober 1995). »Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance«. Inflammation Research. 44 (10): 423–433. doi:10.1007/BF01757699. PMID 8564518. S2CID 37937305.

drugs.com

Use During Pregnancy and Breastfeeding
»Meloxicam Monograph for Professionals«. Drugs.com. AHFS. Arhivirano iz spletišča dne 23. decembra 2018. Pridobljeno 23. decembra 2018.
»Meloxicam official FDA information, side effects, and uses«. Drugs.com. Marec 2010. Arhivirano iz spletišča dne 16. marca 2010. Pridobljeno 17. marca 2010.

fda.gov

»FDA Warns that Using a Type of Pain and Fever Medication in Second Half of Pregnancy Could Lead to Complications«. U.S. Food and Drug Administration (FDA) (tiskovna objava). 15. oktober 2020. Pridobljeno 15. oktobra 2020. Članek vsebuje besedilo iz tega vira, ki je v javni domeni.
»NSAIDs may cause rare kidney problems in unborn babies«. U.S. Food and Drug Administration. 21. julij 2017. Pridobljeno 15. oktobra 2020. Članek vsebuje besedilo iz tega vira, ki je v javni domeni.

nih.gov

pubmed.ncbi.nlm.nih.gov

Noble S, Balfour JA (Marec 1996). »Meloxicam«. Drugs. 51 (3): 424–430, discussion 431–432. doi:10.2165/00003495-199651030-00007. PMID 8882380.
Stamm O, Latscha U, Janecek P, Campana A (Januar 1976). »Development of a special electrode for continuous subcutaneous pH measurement in the infant scalp«. American Journal of Obstetrics and Gynecology. 124 (2): 193–195. doi:10.1016/S0002-9378(16)33297-5. PMID 2012.
Hawkey C, Kahan A, Steinbrück K, Alegre C, Baumelou E, Bégaud B, in sod. (september 1998). »Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment«. British Journal of Rheumatology. 37 (9): 937–945. doi:10.1093/rheumatology/37.9.937. PMID 9783757.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Dequeker J, Hawkey C, Kahan A, Steinbrück K, Alegre C, Baumelou E, in sod. (september 1998). »Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis«. British Journal of Rheumatology. 37 (9): 946–951. doi:10.1093/rheumatology/37.9.946. PMID 9783758.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Wojtulewski JA, Schattenkirchner M, Barceló P, Le Loët X, Bevis PJ, Bluhmki E, Distel M (april 1996). »A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis«. British Journal of Rheumatology. 35 Suppl 1: 22–28. doi:10.1093/rheumatology/35.suppl_1.22. PMID 8630632.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Zeidan, Anwar Z.; Al Sayed, Bashar; Bargaoui, Naceur; Djebbar, Mourad; Djennane, Malik; Donald, Royden; El Deeb, Khamis; Joudeh, Raed A.; Nabhan, Abdullah; Schug, Stephan A. (april 2013). »A Review of the Efficacy, Safety, and Cost-Effectiveness of COX-2 Inhibitors for Africa and the Middle East Region: COX-2 Inhibitors in Pain Management«. Pain Practice. 13 (4): 316–331. doi:10.1111/j.1533-2500.2012.00591.x. PMID 22931375. S2CID 205715393. Pridobljeno 18. maja 2021.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Gates, Brian J.; Nguyen, Trang T.; Setter, Stephen M.; Davies, Neal M. (1. oktober 2005). »Meloxicam: A reappraisal of pharmacokinetics, efficacy and safety«. Expert Opinion on Pharmacotherapy. 6 (12): 2117–2140. doi:10.1517/14656566.6.12.2117. ISSN 1465-6566. PMID 16197363. S2CID 25512189. Pridobljeno 18. maja 2021.
Singh G, Lanes S, Triadafilopoulos G (Julij 2004). »Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam«. The American Journal of Medicine. 117 (2): 100–106. doi:10.1016/j.amjmed.2004.03.012. PMID 15234645.
Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C (Oktober 1995). »Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance«. Inflammation Research. 44 (10): 423–433. doi:10.1007/BF01757699. PMID 8564518. S2CID 37937305.

dailymed.nlm.nih.gov

»Mobic- meloxicam tablet«. DailyMed. Pridobljeno 15. maja 2021.
»Anjeso- meloxicam injection«. DailyMed. Pridobljeno 15. maja 2021.
»Metacam- meloxicam suspension«. DailyMed. Pridobljeno 15. maja 2021.
»Metacam- meloxicam injection, solution«. DailyMed. Pridobljeno 15. maja 2021.

semanticscholar.org

api.semanticscholar.org

Zeidan, Anwar Z.; Al Sayed, Bashar; Bargaoui, Naceur; Djebbar, Mourad; Djennane, Malik; Donald, Royden; El Deeb, Khamis; Joudeh, Raed A.; Nabhan, Abdullah; Schug, Stephan A. (april 2013). »A Review of the Efficacy, Safety, and Cost-Effectiveness of COX-2 Inhibitors for Africa and the Middle East Region: COX-2 Inhibitors in Pain Management«. Pain Practice. 13 (4): 316–331. doi:10.1111/j.1533-2500.2012.00591.x. PMID 22931375. S2CID 205715393. Pridobljeno 18. maja 2021.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)
Gates, Brian J.; Nguyen, Trang T.; Setter, Stephen M.; Davies, Neal M. (1. oktober 2005). »Meloxicam: A reappraisal of pharmacokinetics, efficacy and safety«. Expert Opinion on Pharmacotherapy. 6 (12): 2117–2140. doi:10.1517/14656566.6.12.2117. ISSN 1465-6566. PMID 16197363. S2CID 25512189. Pridobljeno 18. maja 2021.
Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C (Oktober 1995). »Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance«. Inflammation Research. 44 (10): 423–433. doi:10.1007/BF01757699. PMID 8564518. S2CID 37937305.

tandfonline.com

Gates, Brian J.; Nguyen, Trang T.; Setter, Stephen M.; Davies, Neal M. (1. oktober 2005). »Meloxicam: A reappraisal of pharmacokinetics, efficacy and safety«. Expert Opinion on Pharmacotherapy. 6 (12): 2117–2140. doi:10.1517/14656566.6.12.2117. ISSN 1465-6566. PMID 16197363. S2CID 25512189. Pridobljeno 18. maja 2021.

web.archive.org

»Meloxicam Monograph for Professionals«. Drugs.com. AHFS. Arhivirano iz spletišča dne 23. decembra 2018. Pridobljeno 23. decembra 2018.
»Baudax Bio Announces FDA Approval of Anjeso for the Management of Moderate to Severe Pain«. Baudax Bio, Inc. (tiskovna objava). 20. februar 2020. Arhivirano iz spletišča dne 21. februarja 2020. Pridobljeno 20. februarja 2020.
Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. str. 519. ISBN 9783527607495. Arhivirano iz spletišča dne 10. julija 2020. Pridobljeno 30. junija 2020.
»Meloxicam official FDA information, side effects, and uses«. Drugs.com. Marec 2010. Arhivirano iz spletišča dne 16. marca 2010. Pridobljeno 17. marca 2010.

wiley.com

onlinelibrary.wiley.com

Zeidan, Anwar Z.; Al Sayed, Bashar; Bargaoui, Naceur; Djebbar, Mourad; Djennane, Malik; Donald, Royden; El Deeb, Khamis; Joudeh, Raed A.; Nabhan, Abdullah; Schug, Stephan A. (april 2013). »A Review of the Efficacy, Safety, and Cost-Effectiveness of COX-2 Inhibitors for Africa and the Middle East Region: COX-2 Inhibitors in Pain Management«. Pain Practice. 13 (4): 316–331. doi:10.1111/j.1533-2500.2012.00591.x. PMID 22931375. S2CID 205715393. Pridobljeno 18. maja 2021.{{navedi časopis}}: Vzdrževanje CS1: samodejni prevod datuma (povezava)

worldcat.org

Gates, Brian J.; Nguyen, Trang T.; Setter, Stephen M.; Davies, Neal M. (1. oktober 2005). »Meloxicam: A reappraisal of pharmacokinetics, efficacy and safety«. Expert Opinion on Pharmacotherapy. 6 (12): 2117–2140. doi:10.1517/14656566.6.12.2117. ISSN 1465-6566. PMID 16197363. S2CID 25512189. Pridobljeno 18. maja 2021.